AstraZeneca

OTC: AZNCF · Real-Time Price · USD
155.50
-0.25 (-0.16%)
At close: Aug 15, 2025, 3:42 PM
155.75
0.16%
After-hours: Aug 13, 2025, 08:00 PM EDT

AstraZeneca Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
3.13B 2.99B 1.67B 1.83B 1.93B 2.17B 985.07M 1.65B 2.09B 2.26B 778M 923M 247M 553M -636M -2B 764M 1.61B
Depreciation & Amortization
1.39B 1.32B 2.34B 1.82B 1.28B 1.25B 1.36B 1.28B 1.28B 1.5B 1.48B 1.33B 1.36B 1.31B 2.19B 2.79B 753M 797M
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a 579M n/a n/a n/a 619M n/a n/a n/a 615M n/a n/a n/a
Other Working Capital
-345M -436.89M -350M 41M -129M -455M -150M 897M -989M 242M -3.46B 1.07B 587M 1.8B -2.06B 1.21B -353M 1.21B
Other Non-Cash Items
-785M -157.45M -746M -303M 4.08M 2.1B 5.71M -717M -657M -873M -159M -394M -943M -434M -96M -274M -272M -1.68B
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -579M n/a n/a n/a -619M n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-345M -436.89M -350M 41M -129M -452.97M 153.39M 897M -989M 242M 299M 1.07B 587M 1.8B -42M 1.21B -353M 1.21B
Operating Cash Flow
3.39B 3.71B 2.91B 3.38B 3.08B 2.57B 2.51B 3.11B 1.72B 3.13B 2.4B 2.93B 1.25B 3.23B 1.42B 1.72B 892M 1.93B
Capital Expenditures
-1.92B -439.96M -955M -1.36B -671.74M -1.6B -964.48M -879M -483M -1.47B -554M -1.11B -543M -363M -718M -660M -353M -469M
Cash Acquisitions
-267M -362M -274M -281M -2.3B -891.02M -305.19M -273M -184M -426M -189M -342M -288M -242M -218M -9.63B -138M 550M
Purchase of Investments
-188M n/a n/a -29M 31M -97.56M -97.1M -95M -26M -767M 190M -321M -24M -4M 6M -180M -10M -55.03M
Sales Maturities Of Investments
114M 1.03M -31.6M 47M 84M -39.82M 99.29M -68M 81M 19M 182M -2M -9M 53M -15M -15M 107M 28M
Other Investing Acitivies
-1.11B 101.74M -167.4M -834M -306.65M 74.67M 88.5M 94M 92M 1.4B 122M 33M 64M 388M -726M -764M 186M 197M
Investing Cash Flow
-2.11B -1.25B -1.18B -1.51B -2.87B -2.49B -1.18B -1.22B -520M -1.25B -249M -1.74B -800M -168M -913M -10.46B -236M 555M
Debt Repayment
632M 1.12B -608M -2.42B -1.12B 4.89B -240.58M -1.19B -1.44B 1.75B -72M -52M -1.24B -78M -905M 1.6B 7.34B -194.11M
Common Stock Repurchased
n/a -498.42M 817.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-10M -3.43B -3M -1.58B -17M -3.02B -4.76M -1.37B -24.15M -3.09B -97.37M -1.31B -93.17M -2.97B -14.37M -1.39B -17.53M -2.47B
Other Financial Acitivies
-105M 92.77M -83M -59M -91.31M 160M -48.42M -128.88M -108.15M -697.22M -304M 12M -60M -696M -131.63M -68M -60M -72.89M
Financial Cash Flow
518M -2.71B -671M -4.13B -1.22B 2.02B -288.47M -2.73B -1.52B -2.03B -358M -1.43B -1.29B -3.74B -1.05B 142M 7.29B -2.73B
Net Cash Flow
1.82B -222M 994M -2.24B -1.01B 2B 964.15M -852M -357M -155M 1.8B -294M -873M -685M -535M -8.62B 7.96B -309M
Free Cash Flow
1.46B 3.44B 1.95B 2.02B 2.53B 969.66M 1.54B 2.23B 1.24B 1.66B 1.84B 1.82B 705M 2.87B 700M 1.06B 539M 1.47B